Enanta Pharmaceuticals, Inc. (ENTA)

11.88 -0.12 (-1.00%) USD  |  NASDAQ  |  Sep 25, 16:00
11.88 0.00 (0.00%) After-Hours: 19:59
More

Enanta Pharmaceuticals Net Income (Annual) : -81.89M for Sept. 30, 2025

Net Income (Annual) Chart

View Net Income (Annual) for ENTA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Net Income (Annual) Chart
Start Trial

Historical Net Income (Annual) Data

View and export this data back to 2010. Start Trial.
Date Value
September 30, 2025 -81.89M
September 30, 2024 -116.04M
September 30, 2023 -133.82M
September 30, 2022 -121.76M
September 30, 2021 -79.00M
September 30, 2020 -36.17M
September 30, 2019 46.38M
September 30, 2018 71.96M
Date Value
September 30, 2017 17.71M
September 30, 2016 21.67M
September 30, 2015 78.99M
September 30, 2014 34.44M
September 30, 2013 -4.043M
September 30, 2012 1.369M
September 30, 2011 1.565M
September 30, 2010 0.216M

Net Income Definition

Represents net income for the period and date(s) requested in local currency by default.

Read full definition.

Net Income (Annual) Range, Past 5 Years

View Net Income (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Income (Annual) Benchmarks

View Net Income (Annual) Benchmarks
Start Trial
Perspective Therapeutics, Inc. -103.64M
Coherus Oncology, Inc. -183.12M
BridgeBio Pharma, Inc. -732.94M
RenovoRx, Inc. -11.17M
ACADIA Pharmaceuticals, Inc. 391.00M